Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR

K-Number: K841218 · 1984-04-05

ApplicantAnaerobe Systems
Decision Date1984-04-05
Product CodeJSI
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR is the device name listed in this FDA 510(k) record. The listed applicant is Anaerobe Systems. It received FDA 510(k) clearance on 1984-04-05 under 510(k) number K841218. The device is classified under product code JSI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR?

CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR is a medical device that received FDA 510(k) clearance on 1984-04-05. The listed applicant is Anaerobe Systems. The 510(k) number is K841218.

When did CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR receive FDA 510(k) clearance?

CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR received FDA 510(k) clearance on 1984-04-05, under 510(k) number K841218.

Who is the listed applicant for CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR?

The FDA 510(k) record lists Anaerobe Systems as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR?

The FDA product code for CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR is JSI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Anaerobe Systems as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K844381COLISTIN 10 MCG. DIFFERENTIAL DISKK844383KANAMYCIN 1000 MCG DIFFERENTIAL DISKK844382VANCOMYCIN 5MCG DIFFERENTIAL DISKK844380BILE DIFFERENTIAL DISKK841303CAMPYLOBACTER THIOGLYCOLLATE MEDK841142LEVINE EOSIN METHYLENE BLUE AGAR

View all 52 devices →

Related Devices (Code: JSI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K070691BBL CHROMAGAR 0157Becton, Dickinson & COK974428DIPSTREAKNovamed , Ltd.K891593LISTERIA SELECTIVE ENRICHMENT MEDIUMOxoid U.S.A., Inc.K890199DENTOCULT SM-STRIP MUTANSOrion Corp.K882182SALMONELLA-SHIGELLA (SS) AGAR - PRODUCT #P3326Lakewood Biochemical Co., Inc.K881575SELECTIVE STREPTOCOCCUS AGARAcumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑